It is also involved in the inhibition of apoptosis and drug resistance [66–68], whereas HSF1 regulates tumor progression during the metastatic process and is used as a biomarker for tumors that are progressing toward metastasis [69, 70]. The gene discussed is HSF1; the disease is neoplasm.